Potential New Fibromyalgia Drug

FDA panel to review Jazz's potential fibromyalgia drug.
The AP (6/25) reports that "Jazz Pharmaceuticals, Inc. said Thursday that a Food and Drug Administration panel of experts will review the company's potential fibromyalgia drug," JZP-6, "at a meeting on Aug. 20."